Life sciences lead, software signal unknown.
More about RxCelerate
RxCelerate is an outsourced drug discovery and development platform based in Cambridge, UK, founded in 2013 by David Grainger and Jill Reckless. The company specializes in bespoke, integrated programs for small molecules and biologics, aiming to accelerate assets from discovery to preclinical stages. With a team of over 100 experts, RxCelerate emphasizes agile, client-centric collaboration to enhance clinical success and provide cost-effective solutions for biotech startups. The company offers a comprehensive suite of services, including program design and management, in vitro and in vivo assay development, medicinal chemistry, and antibody discovery. RxCelerate utilizes advanced technologies such as RxNfinity™ for in silico screening and Galaxy™ for antibody discovery, ensuring efficient delivery of pharma-grade candidates. Their mission is to improve patients' lives by partnering with life sciences organizations to create tailored drug discovery solutions that address complex biological challenges.
Live roles
Alert me when RxCelerate posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- Kymab / Sanofi Cambridge 47 live
- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- Illumina 6 live
Cambridge-based (Chesterford Research Park) arm of Illumina developing DNA sequencing instruments and technology.
- Tailor Bio 4 live
- Healx 2 live
Cambridge AI-for-rare-disease scale-up; ML platform for drug repurposing and combination discovery. Strong ML/data hiring track record.